retatrutide dosing in trials clinical retatrutide dose dosage a 9-week trip on — LessWrong retatrutide clinical trial dosing frequency – retatrutide dosing phase 2 trial

This is a relative precaution

You will learn a lot on here from other's and albeit your told it is not PA keep an open mind as it still could be

He concluded that GLP-1 receptor agonists have thus far displayed cardioprotective effects and reduced markers of inflammation, although regulators are watching closely for upcoming results on cardiovascular risks with these agents in the near future

Crowe TP, Greenlee MHW, Kanthasamy AG, & Hsu WH

Activation of the GHRHR triggers a signaling cascade involving the Gs protein, adenylate cyclase, and cAMP, leading to the opening of voltage-dependent calcium channels and exocytosis of secretory granules containing GH